<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35227826</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1873-6823</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>101</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Alcohol (Fayetteville, N.Y.)</Title>
          <ISOAbbreviation>Alcohol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Prefrontal cortex parvalbumin interneurons exhibit decreased excitability and potentiated synaptic strength after ethanol reward learning.</ArticleTitle>
        <Pagination>
          <StartPage>17</StartPage>
          <EndPage>26</EndPage>
          <MedlinePgn>17-26</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.alcohol.2022.02.003</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0741-8329(22)00015-5</ELocationID>
        <Abstract>
          <AbstractText>The prefrontal cortex (PFC) is intimately associated with behavioral characteristics of alcohol use disorders, including high motivation to drink and difficulty with moderation. Thus, continued mechanistic research investigating PFC cells and targets altered by ethanol experiences should inform translational efforts to craft new, efficacious treatments. Inhibitory interneurons expressing parvalbumin (PV-INs) comprise only a minor fraction of cells within the PFC, yet these cells are indispensable for coordinating PFC ensemble function, oscillatory activity, and subcortical output. Based on this, PV-INs represent an exciting target for the rational design of breakthrough treatments for alcohol use disorders. Here, we assessed experience-dependent physiological adaptations via ethanol place conditioning. By manipulating the timing of administration relative to conditioning sessions, equivalent ethanol exposure can form either rewarding or aversive memories in different individuals. Here, we found that female mice and male mice on a C57BL/6J background display conditioned place preference (CPP) or aversion (CPA) to an intoxicating dose of ethanol (2 g/kg, intraperitoneal [i.p.]) without overt differences between sexes. Ethanol reward learning was associated with decreased PV-IN excitability in deep layer prelimbic PFC, whereas PV-INs from CPA mice were not different from controls. Furthermore, PV-INs from mice in the CPP group, but not the CPA group, displayed potentiated excitatory synaptic strength that emerged during 1 week of abstinence. Taken together, these findings illustrate that synaptic and intrinsic adaptations associated with ethanol can depend on an individual's experience. These studies provide further context and support for PFC PV-INs as intriguing targets for modulating alcohol associations.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ferranti</LastName>
            <ForeName>Anthony S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Warren Center for Neuroscience Drug Discovery, Nashville, TN, 37232, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Johnson</LastName>
            <ForeName>Kari A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Winder</LastName>
            <ForeName>Danny G</ForeName>
            <Initials>DG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, Vanderbilt University, Nashville, TN, United States; Vanderbilt Center for Addiction Research, Nashville, TN, United States; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Conn</LastName>
            <ForeName>P Jeffrey</ForeName>
            <Initials>PJ</Initials>
            <AffiliationInfo>
              <Affiliation>Warren Center for Neuroscience Drug Discovery, Nashville, TN, 37232, United States; Department of Pharmacology, Vanderbilt University, Nashville, TN, United States; Vanderbilt Center for Addiction Research, Nashville, TN, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Joffe</LastName>
            <ForeName>Max E</ForeName>
            <Initials>ME</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15219, United States; Translational Neuroscience Program, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address: https://twitter.com/mejoffe.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K99 AA027806</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 MH119673</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS031373</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R00 AA025403</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DA042475</GrantID>
            <Acronym>DA</Acronym>
            <Agency>NIDA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R37 AA019455</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R00 AA027806</GrantID>
            <Acronym>AA</Acronym>
            <Agency>NIAAA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R37 NS031373</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Alcohol</MedlineTA>
        <NlmUniqueID>8502311</NlmUniqueID>
        <ISSNLinking>0741-8329</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010320">Parvalbumins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>3K9958V90M</RegistryNumber>
          <NameOfSubstance UI="D000431">Ethanol</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000437" MajorTopicYN="Y">Alcoholism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000431" MajorTopicYN="N">Ethanol</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007395" MajorTopicYN="N">Interneurons</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010320" MajorTopicYN="Y">Parvalbumins</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017397" MajorTopicYN="N">Prefrontal Cortex</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012201" MajorTopicYN="N">Reward</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">addiction</Keyword>
        <Keyword MajorTopicYN="N">drug abuse</Keyword>
        <Keyword MajorTopicYN="N">electrophysiology</Keyword>
        <Keyword MajorTopicYN="N">fast-spiking interneuron</Keyword>
        <Keyword MajorTopicYN="N">plasticity</Keyword>
        <Keyword MajorTopicYN="N">preclinical model</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Interests. PJC receives research support from Acadia Pharmaceuticals and Boehringer Ingelheim and is an inventor on multiple patents for allosteric modulators of metabotropic glutamate receptors. All other authors declare no potential conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>6</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>5</Hour>
          <Minute>47</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35227826</ArticleId>
        <ArticleId IdType="mid">NIHMS1784293</ArticleId>
        <ArticleId IdType="pmc">PMC9117490</ArticleId>
        <ArticleId IdType="doi">10.1016/j.alcohol.2022.02.003</ArticleId>
        <ArticleId IdType="pii">S0741-8329(22)00015-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Alonso-Caraballo Y, Guha SK, and Chartoff EH (2021). The neurobiology of abstinence-induced reward-seeking in males and females. Pharmacol Biochem Behav
200, 173088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7796946</ArticleId>
            <ArticleId IdType="pubmed">33333134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Atallah BV, Bruns W, Carandini M, and Scanziani M (2012). Parvalbumin-expressing interneurons linearly transform cortical responses to visual stimuli. Neuron
73, 159–170.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3743079</ArticleId>
            <ArticleId IdType="pubmed">22243754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartos M, and Elgueta C (2012). Functional characteristics of parvalbumin- and cholecystokinin-expressing basket cells. J Physiol
590, 669–681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3381301</ArticleId>
            <ArticleId IdType="pubmed">22250212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartos M, Vida I, and Jonas P (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci
8, 45–56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17180162</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blaine SK, Wemm S, Fogelman N, Lacadie C, Seo D, Scheinost D, and Sinha R (2020). Association of Prefrontal-Striatal Functional Pathology With Alcohol Abstinence Days at Treatment Initiation and Heavy Drinking After Treatment Initiation. Am J Psychiatry
177, 1048–1059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7606814</ArticleId>
            <ArticleId IdType="pubmed">32854534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bogart LJ, and O'Donnell P (2018). Multiple long-range inputs evoke NMDA currents in prefrontal cortex fast-spiking interneurons. Neuropsychopharmacology
43, 2101–2108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6098111</ArticleId>
            <ArticleId IdType="pubmed">29483660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cobb SR, Buhl EH, Halasy K, Paulsen O, and Somogyi P (1995). Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature
378, 75–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7477292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Courtney KE, Schacht JP, Hutchison K, Roche DJ, and Ray LA (2016). Neural substrates of cue reactivity: association with treatment outcomes and relapse. Addict Biol
21, 3–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4986996</ArticleId>
            <ArticleId IdType="pubmed">26435524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham CL, Clemans JM, and Fidler TL (2002). Injection timing determines whether intragastric ethanol produces conditioned place preference or aversion in mice. Pharmacol Biochem Behav
72, 659–668.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12175463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham CL, Gremel CM, and Groblewski PA (2006). Drug-induced conditioned place preference and aversion in mice. Nat Protoc
1, 1662–1670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17487149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham CL, Smith R, and McMullin C (2003). Competition between ethanol-induced reward and aversion in place conditioning. Learn Behav
31, 273–280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14577550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Menna L, Joffe ME, Iacovelli L, Orlando R, Lindsley CW, Mairesse J, Gressens P, Cannella M, Caraci F, Copani A, et al. (2018). Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system. Neuropharmacology
128, 301–313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6263139</ArticleId>
            <ArticleId IdType="pubmed">29079293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diehl MM, Iravedra-Garcia JM, Moran-Sierra J, Rojas-Bowe G, Gonzalez-Diaz FN, Valentin-Valentin VP, and Quirk GJ (2020). Divergent projections of the prelimbic cortex bidirectionally regulate active avoidance. Elife
9.</Citation>
        </Reference>
        <Reference>
          <Citation>Ferguson BR, and Gao WJ (2018). PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders. Front Neural Circuits
12, 37.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5964203</ArticleId>
            <ArticleId IdType="pubmed">29867371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, Bannerman DM, Rozov A, Whittington MA, Traub RD, Rawlins JN, et al. (2007). Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron
53, 591–604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17296559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George O, Sanders C, Freiling J, Grigoryan E, Vu S, Allen CD, Crawford E, Mandyam CD, and Koob GF (2012). Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking. Proc Natl Acad Sci U S A
109, 18156–18161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3497825</ArticleId>
            <ArticleId IdType="pubmed">23071333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez-Burgos G, Cho RY, and Lewis DA (2015). Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia. Biol Psychiatry
77, 1031–1040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4444373</ArticleId>
            <ArticleId IdType="pubmed">25863358</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, Huang B, Jung J, Zhang H, Fan A, et al. (2017). Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry
74, 911–923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5710229</ArticleId>
            <ArticleId IdType="pubmed">28793133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grusser SM, Wrase J, Klein S, Hermann D, Smolka MN, Ruf M, Weber-Fahr W, Flor H, Mann K, Braus DF, et al. (2004). Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl)
175, 296–302.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15127179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herremans SC, Van Schuerbeek P, De Raedt R, Matthys F, Buyl R, De Mey J, and Baeken C (2015). The Impact of Accelerated Right Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) on Cue-Reactivity: An fMRI Study on Craving in Recently Detoxified Alcohol-Dependent Patients. PLoS One
10, e0136182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4546410</ArticleId>
            <ArticleId IdType="pubmed">26295336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hippenmeyer S, Vrieseling E, Sigrist M, Portmann T, Laengle C, Ladle DR, and Arber S (2005). A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biol
3, e159.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1084331</ArticleId>
            <ArticleId IdType="pubmed">15836427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holleran KM, and Winder DG (2017). Preclinical voluntary drinking models for alcohol abstinence-induced affective disturbances in mice. Genes Brain Behav
16, 8–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27621103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hughes BA, Crofton EJ, O'Buckley TK, Herman MA, and Morrow AL (2020). Chronic ethanol exposure alters prelimbic prefrontal cortical Fast-Spiking and Martinotti interneuron function with differential sex specificity in rat brain. Neuropharmacology
162, 107805.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7027948</ArticleId>
            <ArticleId IdType="pubmed">31589884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwa LS, Chu A, Levinson SA, Kayyali TM, DeBold JF, and Miczek KA (2011). Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol. Alcohol Clin Exp Res
35, 1938–1947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3166538</ArticleId>
            <ArticleId IdType="pubmed">21631540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joffe ME, Santiago CI, Oliver KH, Maksymetz J, Harris NA, Engers JL, Lindsley CW, Winder DG, and Conn PJ (2020a). mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects. Neuron
105, 46–59 e43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6952546</ArticleId>
            <ArticleId IdType="pubmed">31735403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joffe ME, Vitter SR, and Grueter BA (2017). GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation. Neuropharmacology
112, 172–180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5031515</ArticleId>
            <ArticleId IdType="pubmed">27012890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joffe ME, Winder DG, and Conn PJ (2020b). Contrasting sex-dependent adaptations to synaptic physiology and membrane properties of prefrontal cortex interneuron subtypes in a mouse model of binge drinking. Neuropharmacology, 108126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7544622</ArticleId>
            <ArticleId IdType="pubmed">32781000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klenowski PM (2018). Emerging role for the medial prefrontal cortex in alcohol-seeking behaviors. Addict Behav
77, 102–106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28992574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knoblich U, Huang L, Zeng H, and Li L (2019). Neuronal cell-subtype specificity of neural synchronization in mouse primary visual cortex. Nat Commun
10, 2533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6557841</ArticleId>
            <ArticleId IdType="pubmed">31182715</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koob GF (2014). Neurocircuitry of alcohol addiction: synthesis from animal models. Handb Clin Neurol
125, 33–54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25307567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Cabrera-Garcia D, Salling MC, Au E, Yang G, and Harrison NL (2021). Alcohol reduces the activity of somatostatin interneurons in the mouse prefrontal cortex: A neural basis for its disinhibitory effect?
Neuropharmacology
188, 108501.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8820125</ArticleId>
            <ArticleId IdType="pubmed">33636191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marcus DJ, Bedse G, Gaulden AD, Ryan JD, Kondev V, Winters ND, Rosas-Vidal LE, Altemus M, Mackie K, Lee FS, et al. (2020). Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening. Neuron
105, 1062–1076 e1066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7992313</ArticleId>
            <ArticleId IdType="pubmed">31948734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matta JA, Pelkey KA, Craig MT, Chittajallu R, Jeffries BW, and McBain CJ (2013). Developmental origin dictates interneuron AMPA and NMDA receptor subunit composition and plasticity. Nat Neurosci
16, 1032–1041.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4132661</ArticleId>
            <ArticleId IdType="pubmed">23852113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGarry LM, and Carter AG (2016). Inhibitory Gating of Basolateral Amygdala Inputs to the Prefrontal Cortex. J Neurosci
36, 9391–9406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5013187</ArticleId>
            <ArticleId IdType="pubmed">27605614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medina KL, McQueeny T, Nagel BJ, Hanson KL, Schweinsburg AD, and Tapert SF (2008). Prefrontal cortex volumes in adolescents with alcohol use disorders: unique gender effects. Alcohol Clin Exp Res
32, 386–394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2825148</ArticleId>
            <ArticleId IdType="pubmed">18302722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melon LC, Nasman JT, John AS, Mbonu K, and Maguire JL (2018). Interneuronal delta-GABAA receptors regulate binge drinking and are necessary for the behavioral effects of early withdrawal. Neuropsychopharmacology.</Citation>
        </Reference>
        <Reference>
          <Citation>Miyamae T, Chen K, Lewis DA, and Gonzalez-Burgos G (2017). Distinct Physiological Maturation of Parvalbumin-Positive Neuron Subtypes in Mouse Prefrontal Cortex. J Neurosci
37, 4883–4902.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5426180</ArticleId>
            <ArticleId IdType="pubmed">28408413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pati D, Pina MM, and Kash TL (2019). Ethanol-induced conditioned place preference and aversion differentially alter plasticity in the bed nucleus of stria terminalis. Neuropsychopharmacology
44, 1843–1854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6785142</ArticleId>
            <ArticleId IdType="pubmed">30795004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patton MS, Heckman M, Kim C, Mu C, and Mathur BN (2021). Compulsive alcohol consumption is regulated by dorsal striatum fast-spiking interneurons. Neuropsychopharmacology
46, 351–359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7852608</ArticleId>
            <ArticleId IdType="pubmed">32663841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Philip NS, Sorensen DO, McCalley DM, and Hanlon CA (2020). Non-invasive Brain Stimulation for Alcohol Use Disorders: State of the Art and Future Directions. Neurotherapeutics
17, 116–126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7007491</ArticleId>
            <ArticleId IdType="pubmed">31452080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pickens CL, Airavaara M, Theberge F, Fanous S, Hope BT, and Shaham Y (2011). Neurobiology of the incubation of drug craving. Trends Neurosci
34, 411–420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3152666</ArticleId>
            <ArticleId IdType="pubmed">21764143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Povysheva NV, Zaitsev AV, Gonzalez-Burgos G, and Lewis DA (2013). Electrophysiological heterogeneity of fast-spiking interneurons: chandelier versus basket cells. PLoS One
8, e70553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3741302</ArticleId>
            <ArticleId IdType="pubmed">23950961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radke AK, Jury NJ, Delpire E, Nakazawa K, and Holmes A (2017). Reduced ethanol drinking following selective cortical interneuron deletion of the GluN2B NMDA receptors subunit. Alcohol
58, 47–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5444088</ArticleId>
            <ArticleId IdType="pubmed">28109345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Royer S, Zemelman BV, Losonczy A, Kim J, Chance F, Magee JC, and Buzsaki G (2012). Control of timing, rate and bursts of hippocampal place cells by dendritic and somatic inhibition. Nat Neurosci
15, 769–775.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4919905</ArticleId>
            <ArticleId IdType="pubmed">22446878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salling MC, Jane Skelly M, Avegno E, Regan S, Zeric T, Nichols E, and Harrison NL (2018). Alcohol consumption during adolescence in a mouse model of binge drinking alters the intrinsic excitability and function of the prefrontal cortex through a reduction in the hyperpolarization-activated cation current. J Neurosci.</Citation>
        </Reference>
        <Reference>
          <Citation>Salling MC, and Martinez D (2016). Brain Stimulation in Addiction. Neuropsychopharmacology
41, 2798–2809.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5061891</ArticleId>
            <ArticleId IdType="pubmed">27240657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seif T, Chang SJ, Simms JA, Gibb SL, Dadgar J, Chen BT, Harvey BK, Ron D, Messing RO, Bonci A, et al. (2013). Cortical activation of accumbens hyperpolarization-active NMDARs mediates aversion-resistant alcohol intake. Nat Neurosci
16, 1094–1100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3939030</ArticleId>
            <ArticleId IdType="pubmed">23817545</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siciliano CA, Noamany H, Chang CJ, Brown AR, Chen X, Leible D, Lee JJ, Wang J, Vernon AN, Vander Weele CM, et al. (2019). A cortical-brainstem circuit predicts and governs compulsive alcohol drinking. Science
366, 1008–1012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6989100</ArticleId>
            <ArticleId IdType="pubmed">31754002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sohal VS, Zhang F, Yizhar O, and Deisseroth K (2009). Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature
459, 698–702.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3969859</ArticleId>
            <ArticleId IdType="pubmed">19396159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorg SF, Taylor MJ, Alhassoon OM, Gongvatana A, Theilmann RJ, Frank LR, and Grant I (2012). Frontal white matter integrity predictors of adult alcohol treatment outcome. Biol Psychiatry
71, 262–268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4208753</ArticleId>
            <ArticleId IdType="pubmed">22047719</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trantham-Davidson H, Burnett EJ, Gass JT, Lopez MF, Mulholland PJ, Centanni SW, Floresco SB, and Chandler LJ (2014). Chronic alcohol disrupts dopamine receptor activity and the cognitive function of the medial prefrontal cortex. J Neurosci
34, 3706–3718.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3942586</ArticleId>
            <ArticleId IdType="pubmed">24599469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang J, Fan Y, Dong Y, Ma M, Ma Y, Dong Y, Niu Y, Jiang Y, Wang H, Wang Z, et al. (2016). Alterations in Brain Structure and Functional Connectivity in Alcohol Dependent Patients and Possible Association with Impulsivity. PLoS One
11, e0161956.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5004845</ArticleId>
            <ArticleId IdType="pubmed">27575491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, et al. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet
382, 1575–1586.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23993280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodward JJ, and Pava MJ (2009). Effects of ethanol on persistent activity and up-States in excitatory and inhibitory neurons in prefrontal cortex. Alcohol Clin Exp Res
33, 2134–2140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2921674</ArticleId>
            <ArticleId IdType="pubmed">19764936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X, Meng YJ, Tao YJ, Deng RH, Wang HY, Li XJ, Wei W, Hua Y, Wang Q, Deng W, et al. (2021). Functional Connectivity of Nucleus Accumbens and Medial Prefrontal Cortex With Other Brain Regions During Early-Abstinence Is Associated With Alcohol Dependence and Relapse: A Resting-Functional Magnetic Resonance Imaging Study. Front Psychiatry
12, 609458.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7876376</ArticleId>
            <ArticleId IdType="pubmed">33584384</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
